Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Revolution Medicines Inc. Warrant (NASDAQ : RVMDW ) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
Quote
| Last: | $1.93 |
|---|---|
| Change Percent: | 1.58% |
| Open: | $1.98 |
| Close: | $1.90 |
| High: | $1.9999 |
| Low: | $1.81 |
| Volume: | 22,848 |
| Last Trade Date Time: | 04/02/2026 03:59:46 pm |
Stock Data
| Market Cap: | $18,581,874,872 |
|---|---|
| Float: | 177,467,581 |
| Insiders Ownership: | N/A |
| Institutions: | 132 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.revmed.com |
| Country: | US |
| City: | Redwood City |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Revolution Medicines Inc. Warrant (NASDAQ: RVMDW).
